HLB Life Science Co. Ltd (067630) — Cash Flow Quality Index
HLB Life Science Co. Ltd (067630) has a Cash Flow Quality Index of -5.16x as of December 2024. Operating cash flow of ₩-32.01 Billion is below net income of ₩6.21 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore HLB Life Science Co. Ltd (067630) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
HLB Life Science Co. Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for HLB Life Science Co. Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of HLB Life Science Co. Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for HLB Life Science Co. Ltd (2014–2024)
Year-by-year earnings quality comparison for HLB Life Science Co. Ltd. For live market cap and the full company financial profile, see 067630 market cap overview.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -5.16x | ₩-32.01 Billion | ₩6.21 Billion | ▼ -13149.7% |
| 2017 | -0.04x | ₩-302.04 Million | ₩7.76 Billion | ▼ -100.5% |
| 2014 | 7.43x | ₩10.43 Billion | ₩1.40 Billion | — |